Recent

% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

  • traderguystocks traderguystocks Nov 21, 2012 11:52 AM Flag

    Piper Jaffary "NEAR TERM for SRPT $60-$80 AFTER APPROVAL $160" link

    Piper Jaffary "NEAR TERM for SRPT $60-$80 AFTER APPROVAL $160 " **link**
    Street Insider
    Sarepta Therapeutics (SRPT) Jumps on Bullish CommentS
    November 21, 2012 9:18 AM EST
    Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is seeing strong pre-open action following positive comments from analysts at Piper Jaffray. The firm said it has the potential to be a $160/share stock but a nearer-term range could be $60-$80/share.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Based on the size of the market, especially with the ANCHOR indication in hand, if AMRN GIA, it will be a $100+++ stock.
      SRPT has a great and much needed product that's going to be approved soon, but the market is not even close to the size of the market Vascepa will be competing in.

      Sentiment: Strong Buy

 
AMRN
2.21-0.02(-0.90%)Aug 31 4:00 PMEDT